SCHEMBL5042633

SCHEMBL5042633

CS(=O)(=O)Cc1c(-c2ccccc2)nc2ccccc2c1C(=O)NCCc1ccccc1C#N

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
TACR3 P29371 13/20 0.55
TP53 P04637 1/20 0.46
TACR2 P21452 4/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
OPRM1 P35372 1/20 0.41
HIF1A Q16665 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
DHODH Q02127 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041963 0.88 TACR3 (0.55) LMNATACR3TP53TACR2CYP1A2
SCHEMBL4665602 0.86 LMNA (0.57) LMNATACR3TP53TACR2CYP1A2
SCHEMBL4668727 0.86 LMNA (0.53) LMNATACR3TP53TACR2CYP1A2
SCHEMBL4665569 0.86 TACR3 (0.56) LMNATACR3TP53CYP1A2CYP3A4
SCHEMBL5045996 0.86 LMNA (0.57) LMNATACR3TP53TACR2CYP1A2
SCHEMBL4665580 0.85 LMNA (0.55) LMNATACR3TP53TACR2CYP1A2
SCHEMBL5140190 0.85 LMNA (0.76) LMNATACR3TP53TACR2ALDH1A1
SCHEMBL4667328 0.84 LMNA (0.53) LMNATACR3TP53TACR2CYP1A2
SCHEMBL5042219 0.84 LMNA (0.55) LMNATACR3TP53TACR2CYP1A2
SCHEMBL5045776 0.83 CYP2D6 (0.56) LMNATACR3TP53TACR2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928835-A1 ALKYL SULFOXIDE QUINOLINES AS NK-3 RECEPTOR LIGANDS Astra Zeneca AB (SE) 2008-06-11 EP claimed
WO-2007035158-A1 ALKYL SULFOXIDE QUINOLINES AS NK-3 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2007-03-29 WO claimed